Treatment Efficacy Clinical Trial
Official title:
A Prospective, Randomised, Controlled, Open-label, Non-inferiority Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection Under Suppressive Early Standard of Care Antiretroviral Therapy
Long term toxicity of combination antiretroviral therapy (cART) is a substantial contributor to morbidity and mortality in chronically infected HIV positive individuals. To date it is still debated, whether long term nucleoside reverse transcriptase inhibitors (NRTI's) -sparing regimens are practicable or even superior compared to standard of care cART in terms of efficacy, safety and tolerability. In addition, data about efficacy of integrase inhibitor (INSTI) based monotherapy is lacking. We aim at investigating the efficacy of standard of care combination antiretroviral therapy with a simplified dolutegravir monotherapy in patients with a primary HIV-1 infection under suppressive early standard of care antiretroviral therapy. Briefly, hundred-thirty-eight patients with a documented primary HIV1- infection (PHI) will be recruited from the Zurich Primary HIV-1 Infection Study (ZHPI), which is an open label, non-randomized, observational, single-center study (http://clinicaltrials.gov, ID 5 NCT00537966). All subjects formerly underwent early cART consisting of either a protease inhibitor (PI) or a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a INSTI in combination with two NRTIs at the time point of enrolment in the ZPHI and must be under a fully suppressive ART (i.e., <50 copies/ml) for at least 48 weeks at the time point of randomisation. The primary end point is the proportion of individuals with a viral failure at week 48 or before.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04508803 -
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT05087381 -
Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community
|
Phase 4 | |
Recruiting |
NCT06221722 -
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
|
||
Terminated |
NCT03503968 -
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06460883 -
Effects of Eccentric Banded Leg Curls Versus Eccentric Cable Leg Curls Exercises in Cricket Players
|
N/A | |
Completed |
NCT02572947 -
A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients
|
Phase 2 | |
Completed |
NCT05144295 -
Lubiprostone for Functional Constipation in the Under 18 Years Patients
|
Phase 3 | |
Recruiting |
NCT05813951 -
Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock
|
N/A | |
Completed |
NCT03345160 -
Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
|
Phase 2 |